| US 7,462,717 B2 | ||
| C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants | ||
| José Ignacio Andrés-Gil, Madrid (Spain); Manuel Jesús Alcázar-Vaca, Toledo (Spain); Maria Encarnacion Matesanz-Ballesteros, Toledo (Spain); Margaretha Henrica Maria Bakker, Alsbach-Haehnlein (Germany); and Antonius Adrianus Hendrikus Petrus Megens, Beerse (Belgium) | ||
| Assigned to Janssen Pharmaceutica N.V., Beerse (Belgium) | ||
| Appl. No. 10/524,989 PCT Filed Aug. 19, 2003, PCT No. PCT/EP03/09532 § 371(c)(1), (2), (4) Date Feb. 18, 2005, PCT Pub. No. WO2004/018482, PCT Pub. Date Mar. 04, 2004. |
||
| Claims priority of application No. 02078844 (EP), filed on Aug. 21, 2002. | ||
| Prior Publication US 2006/0122167 A1, Jun. 08, 2006 | ||
| Int. Cl. A61K 31/55 (2006.01); A61K 31/5377 (2006.01); A61K 31/496 (2006.01); C07D 498/04 (2006.01); C07D 413/00 (2006.01) | ||
| U.S. Cl. 544—368 [544/99; 544/137; 544/361; 514/217.1; 514/229.5; 514/232.5; 514/253.03; 514/254.04; 514/293; 514/321; 540/599; 540/603; 546/83; 546/198] | 11 Claims |
1. A compound according to the general Formula (I)
![]() X is CH2, N—R7, S or O;
R7 is selected from the group consisting of hydrogen, alkyl, Ar, Ar-alkyl, alkylcarbonyl, alkyloxycarbonyl and mono- and di(alkyl)aminocarbonyl;
R1, R2, R14 R15 are each, independently from each other, selected from the group consisting of
hydrogen;
halo;
a radical selected from the group consisting of hydroxy, —OSO2H, —OSO2CH3, alkyloxy, alkyloxyalkyloxy, alkyloxyalkyloxyalkyloxy, tetrahydrofuranyloxy, alkylcarbonyloxy, alkyloxyalkylcarbonyloxy,
pyridinylcarbonyloxy, alkylcarbonyloxyalkyloxy, alkyloxyalkylcarbonyloxyalkyloxy, alkyloxycarbonyloxy, alkenyloxy, alkenylcarbonyloxy,
mono- or di(alkyl)aminoalkyloxy, mono- or di(alkyl)aminocarbonyloxyalkyloxy;
a radical selected from the group consisting of cyano, CN—OH, CN-oxyalkyl, alkyl, alkyloxyalkyl, alkyloxyalkyloxyalkyl, alkyloxyalkyloxyalkyloxyalkyl,
alkylcarbonylalkyl, alkylcarbonyloxyalkyl, alkyloxycarbonylalkyl, Ar-alkyl, Arcarbonylalkyl, Ar-oxyalkyl, mono- or di(alkyl)aminoalkyl,
mono- or di(alkylcarbonyl)aminoalkyl, mono- or di(alkyl)aminocarbonylalkyl, Het-alkyl, formyl, alkylcarbonyl, alkyloxycarbonyl,
alkyloxyalkylcarbonyl, mono- or di(alkyl)aminocarbonyl, Ar-carbonyl and Ar-oxycarbonyl;
—N—R10R11 wherein R10 and R11 each, independently from each other, are selected from the group consisting of hydrogen, alkyl, Ar, pyridinyl, Ar-alkyl, pyrrolidinylalkyl,
piperidinylalkyl, homopiperidinylalkyl, piperazinylalkyl, morpholinylalkyl, mono- or di(alkyl)aminoalkyl, alkylcarbonyl, alkenylcarbonyl,
Ar-carbonyl, pyridinylcarbonyl, alkyloxycarbonyl, mono- or di(alkyl)aminocarbonyl, mono- or di(Ar)aminocarbonyl, mono- or
di(alkyloxycarbonylalkyl)aminocarbonyl, pyrrolidinylcarbonyl, aminoiminomethyl, alkylaminoiminomethyl, N-benzylpiperazinyliminomethyl,
alkylsulphonyl and Ar-sulphonyl; or
R10 and R11 may be taken together and with the N may form a monovalent radical selected from the group consisting of
![]() wherein:
R12 is selected from the group consisting of hydrogen, alkyl, Ar, Ar-alkyl, Ar-alkenyl, alkylcarbonyl, alkyloxycarbonyl, alkyloxyalkylcarbonyl
and mono- or di(alkyl)aminocarbonyl;
each R13 is, independently from each other, selected from the group consisting of alkyl, oxo, Ar, Ar-alkyl, Ar-alkenyl and alkyloxycarbonyl;
q is an integer ranging from 0 to 6;
alkylthio;
Ar and Het;
with the provisio that at least one of R14 and R15 is not hydrogen;
Ar is phenyl or naphthyl, optionally substituted with one or more halo, cyano, oxo, hydroxy, alkyl, formyl, alkyloxy or amino
radicals;
Het is a heterocyclic radical selected from the group consisting of Het1, Het2 and Het3;
Het1 is an aliphatic monocyclic heterocyclic radical selected from the group consisting of pyrrolidinyl, dioxolyl, imidazolidinyl,
pyrrazolidinyl, piperidinyl, dioxyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl and tetrahydrofuryl;
Het2 is a semi-aromatic monocyclic heterocyclic radical selected from the group consisting of 2H-pyrrolyl, pyrrolinyl, imidazolinyl
and pyrrazolinyl;
Het3 is an aromatic monocyclic heterocyclic radical selected from the group consisting of pyrrolyl, pyrazolyl, imidazolyl, furyl,
thienyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl and triazinyl; or an
aromatic bicyclic heterocyclic radical selected from the group of quinolinyl, quinoxalinyl, indolyl, benzimidazolyl, benzoxazolyl,
benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzofuranyl and benzothienyl; wherein each Het-radical may optionally be
substituted on either a carbon or heteroatom with halo, hydroxy, alkyloxy, alkyl, Ar, Ar-alkyl, formyl, alkylcarbonyl or pyridinyl;
a and b are asymmetric centers;
(CH2)m is a straight hydrocarbon chain of m carbon atoms, m being an integer ranging from 1 to 4;
Pir is a radical according to any one of Formula (IIa), (IIb) or (IIc)
![]() optionally substituted with n radicals R8, wherein
each R is independently from each other, selected from the group consisting of hydroxy, amino, nitro, cyano, halo and alkyl;
n is an integer ranging from 0 to 5;
R9 is selected from the group consisting of hydrogen, alkyl and formyl;
R3 represents an optionally substituted aromatic homocyclic or heterocyclic ring system together with an optionally substituted
and partially or completely hydrogenated hydrocarbon chain of 1 to 6 atoms long with which said ring system is attached to
the Pir radical and of which may contain one or more heteroatoms selected from the group of O, N and S;
alkyl represents a straight or branched saturated hydrocarbon radical having from 1 to 6 carbon atoms or a cyclic saturated
hydrocarbon radical having from 3 to 6 carbon atoms, optionally substituted with one or more halo, cyano, oxo, hydroxy, formyl
or amino radicals and
alkenyl represents a straight or branched unsaturated hydrocarbon radical having one or more double bonds, optionally substituted
with one or more halo, cyano, oxo, hydroxy, formyl or amino radicals.
|